6-(3,5-dimethylphenyl)sulfanyl-1-(ethoxymethyl)-5-ethyl-2-sulfanylidenepyrimidin-4-one

• 常用名: 6-(3,5-dimethylphenyl)sulfanyl-1-(ethoxymethyl)-5-ethyl-2-sulfanylidenepyrimidin-4-one
• 英文名: 6-(3,5-dimethylphenyl)sulfanyl-1-(ethoxymethyl)-5-ethyl-2-sulfanylidenepyrimidin-4-one
• CAS号: 136011-45-5
• 分子量: 350.49900
• 密度: 1.25g/cm3
• 沸点: N/A
• 分子式: C₁₇H₂₂N₂O₂S₂
• 熔点: N/A
• 闪点: N/A

名称

• 英文名: 6-(3,5-dimethylphenyl)sulfanyl-1-(ethoxymethyl)-5-ethyl-2-sulfanylidenepyrimidin-4-one

物理化学性质

• 密度: 1.25g/cm3
• 分子式: C₁₇H₂₂N₂O₂S₂
• 分子量: 350.49900
• 精确质量: 350.11200
• PSA: 104.67000
• LogP: 4.64260
• InChIKey: OQZISUZIYBKHTQ-UHFFFAOYSA-N
• SMILES: CCOCn1c(Sc2cc(C)cc(C)c2)c(CC)c(=O)[nH]c1=S
• 折射率: 1.629

靶点实验

查看更多实验

实验名称：Effective concentration required for 50% protection of MT-4 cells against the cytopat... 来源：ChEMBL 靶标：Human immunodeficiency virus 1 External Id：CHEMBL712346

实验名称：Concentration required to inhibit replication of HIV-1 HTLV-IIIB strain in PBL (perip... 来源：ChEMBL 靶标：N/A External Id：CHEMBL764493

实验名称：Ratio of the EC50 against HIV-1 infected MT-4 cells and CC50 against mock infected MT... 来源：ChEMBL 靶标：MT4 External Id：CHEMBL838556

实验名称：Concentration required to inhibit replication of HIV-2 LAV-2rod strain in MT-4 cells 来源：ChEMBL 靶标：MT4 External Id：CHEMBL713411

实验名称：Inhibitory concentration against HIV-1 reverse transcriptase 来源：ChEMBL 靶标：Reverse transcriptase/RNaseH External Id：CHEMBL804270

实验名称：Concentration required to reduce viability of mock-infected MT-4 cells 来源：ChEMBL 靶标：NON-PROTEIN TARGET External Id：CHEMBL844556

实验名称：Antiviral activity against HIV1 3B infected in human MT4 cells assessed as protection... 来源：ChEMBL 靶标：Human immunodeficiency virus 1 External Id：CHEMBL3243451

实验名称：Concentration required to reduce viability of Mock infected PBL (peripheral blood lym... 来源：ChEMBL 靶标：N/A External Id：CHEMBL764491

实验名称：HIV Cellular Data 来源：NIAID 靶标：N/A External Id：HIV Cellular Data

共9条，当前第1页，共1页

1

英文别名

• 1-EtOMe-6XylylS-5Et2thio U
• E-EPU-SdM
• 5-Ethyl-1-ethoxymethyl-6-(3,5-dimethylphenylthio)-2-thiouracil